Arun Krishna, PhD, is the Head of Franchise, Oncology, at AstraZeneca. He was born in India, where he obtained a bachelor’s degree in Engineering, before moving to the United States to complete a doctorate degree in biostatistics at North Carolina State University. His PhD research focussed on methodologies that can be applied to novel ways of detecting and treating cancers through classifying gene expression data.
Arun previously worked as UK Business Unit Director, Respiratory and Head Commercial Operations, at Novartis. He has also worked at SAS analytics and Merck in global and in-market leadership roles. His expertise spans clinical development, new product strategy, market access and policy.
He is a proud father of two.